Isosceles Pharmaceuticals
Location: Wilmington, United States, office address not availableisoscelespharma.com
Isosceles Pharmaceuticals is developing IPI201, a synthetic small-molecule immunotherapy adjuvant designed to convert immunologically cold tumors into…
Founders and contacts
- Founders1 name, locked
- Founder emailsBeing confirmed, locked
- LinkedInCompany page, locked
Explore
More startups in Wilmington
Is Isosceles Pharmaceuticals yours? Feature it on the map for $49 a month, in front of everyone who opens it.
Are you a founder of Isosceles Pharmaceuticals and want your details removed? Write to us and we remove them within 72 hours.